Skip to main content
David Swoboda, MD, Oncology, Tampa, FL

DavidMichaelSwobodaMD

Oncology Tampa, FL

Hematologic Oncology

Malignant Hematologist at TGH Cancer Institute

Dr. Swoboda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Swoboda's full profile

Already have an account?

  • Office

    Tampa General Hospital Cancer Instititute
    3 Tampa General Cir
    Tampa, FL 33606
    Phone+1 813-844-7585
    Fax+1 561-253-3985

Summary

  • Dr. David Swoboda is an oncologist in Tampa, FL and is affiliated with Tampa General Hospital. He received his medical degree from Florida State University College of Medicine and has been in practice 2 years. He specializes in hematologic oncology and is experienced in acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndromes , and leukemia. He has more than 20 publications and over 100 citings.

Education & Training

  • Florida State University College of Medicine
    Florida State University College of MedicineClass of 2014

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2018 - 2026
  • VA State Medical License
    VA State Medical License 2014 - 2020
  • DC State Medical License
    DC State Medical License 2016 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • T315I-mutated myeloid sarcoma  
    Yumeng Zhang, David M. Swoboda, Aditya Grover, Lisa Nodzon, Ling Zhang, Javier Pinilla-Ibarz, Leukemia Research Reports, 8/17/2019

Abstracts/Posters

  • OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
    David M Swoboda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019